Monitoring the effects of bempedoic acid during pregnancy
Official title: A Post-marketing, Long-term, Observational, Descriptive Study to Assess the Risk of Pregnancy and Maternal Complications and Adverse Effects on the Developing Fetus, Neonate, and Infant Among Women Exposed to Bempedoic Acid or Bempedoic Acid/Ezetimibe Fixed Combination Drug Product (FCDP) During Pregnancy
Run by Esperion Therapeutics, Inc. · NCT05103254 · Data updated 2026-11-12
This study looks at how bempedoic acid affects pregnant women and their babies during pregnancy and the first year of life.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 20 (estimated) |
| Sponsor | Esperion Therapeutics, Inc. Industry-sponsored |
| Locations | 1 site (Morrisville, North Carolina) |
| Status | Recruiting |
| Started | September 1, 2021 |
| Main results expected | May 2032 |
| Study ends | May 2032 |
| Registry record updated | May 17, 2024 |
| Trial ID | NCT05103254 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pregnant women who have taken at least one dose of bempedoic acid or the bempedoic acid/ezetimibe combination during their pregnancy.
✕Probably not a fit
Patients who have not been exposed to bempedoic acid or the combination therapy during pregnancy will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on pregnant females who have been exposed to bempedoic acid or a fixed combination of bempedoic acid and ezetimibe. It aims to collect data on the outcomes of these pregnancies and the health of infants during their first year of life. The study will gather information on both maternal and infant health to better understand the implications of bempedoic acid exposure during pregnancy. Participants will be monitored throughout their pregnancy and for a year after giving birth.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the safety and effects of bempedoic acid during pregnancy, guiding future treatment options for pregnant women with hyperlipidemia.
How similar studies have gone: While there may be limited data on the specific effects of bempedoic acid during pregnancy, similar observational studies on drug exposure in pregnancy have provided important safety information in the past.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Exposure to at least 1 dose of bempedoic acid or bempedoic acid/ezetimibe FCDP at any time during pregnancy (from first day of last menstrual period \[LMP\] to pregnancy outcome Exclusion Criteria:
Where it's running
-
Evidera, PPD business unit
Morrisville, North Carolina, United States Recruiting
Study contacts
- Study coordinator: Esperion Therapuetics
- Email: Bempedoic.Acid.PSP@ppd.com
- Phone: 1 833 377 7633 (Option 5)
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy
This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.
-
Effective Communication in VBAC Counseling
This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.
-
Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy
This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.
-
Compare spinal-epidural versus general anesthesia for babies after cesarean delivery
This trial tests whether the type of anesthesia used for cesarean delivery affects newborn hearing in babies.
-
Pregnant women weight-management support via an app and care model
Aims to try a smartphone-based weight-management program plus professional support for pregnant women to see if it helps manage gestational weight and promote healthy behaviors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.